نتائج البحث - "Katja Seipel"

1

Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma

المؤلفون: Alexander D. Heini, Ulrike Bacher, Naomi Porret, Gertrud Wiedemann, Myriam Legros, Denise Stalder Zeerleder, Katja Seipel, Urban Novak, Michael Daskalakis, Thomas Pabst

المصدر: Heini, Alexander D; Bacher, Ulrike; Porret, Naomi; Wiedemann, Gertrud; Legros, Myriam; Stalder Zeerleder, Denise; Seipel, Katja; Novak, Urban; Daskalakis, Michael; Pabst, Thomas (2022). Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma. Cells, 11(17) MDPI 10.3390/cells11172747 <http://dx.doi.org/10.3390/cells11172747Test>

مصطلحات موضوعية: Adult, Male, Receptors, Chimeric Antigen, Hematopoietic Stem Cell Transplantation, 610 Medicine & health, General Medicine, Lymphoma, Mantle-Cell, Immunotherapy, Adoptive, Transplantation, Autologous, Antibodies, Bispecific, Humans, Female, Neoplasm Recurrence, Local

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6a622c2d627d864036d167ace8faef1Test

2

Rationale for Combining the BCL2 Inhibitor Venetoclax with the PI3K Inhibitor Bimiralisib in the Treatment of IDH2- and FLT3-Mutated Acute Myeloid Leukemia

المؤلفون: Katja Seipel, Yvo Brügger, Harpreet Mandhair, Ulrike Bacher, Thomas Pabst

المصدر: International Journal of Molecular Sciences; Volume 23; Issue 20; Pages: 12587
Seipel, Katja; Brügger, Yvo; Mandhair, Harpreet; Bacher, Ulrike; Pabst, Thomas (2022). Rationale for Combining the BCL2 Inhibitor Venetoclax with the PI3K Inhibitor Bimiralisib in the Treatment of IDH2-and FLT3-Mutated Acute Myeloid Leukemia. International journal of molecular sciences, 23(20) MDPI 10.3390/ijms232012587 <http://dx.doi.org/10.3390/ijms232012587Test>

مصطلحات موضوعية: Adult, Mitogen-Activated Protein Kinase Kinases, acute myeloid leukemia (AML), B-cell lymphoma-2 (BCL2), venetoclax (ABT-199), isocitrate dehydrogenase 2 (IDH2), bimiralisib (PQR309), mammalian target of rapamycin (mTOR), phosphoinositide 3-kinase (PI3K), Fms-related receptor tyrosine kinase 3 (FLT3), protein tyrosine phosphatase non-receptor type 11 (PTPN11), TOR Serine-Threonine Kinases, Organic Chemistry, 610 Medicine & health, Antineoplastic Agents, General Medicine, Bridged Bicyclo Compounds, Heterocyclic, Catalysis, Computer Science Applications, Inorganic Chemistry, Phosphatidylinositol 3-Kinases, Leukemia, Myeloid, Acute, Proto-Oncogene Proteins c-bcl-2, fms-Like Tyrosine Kinase 3, Humans, Myeloid Cell Leukemia Sequence 1 Protein, Physical and Theoretical Chemistry, Protein Kinase Inhibitors, Molecular Biology, Spectroscopy

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9891a6780c13de04faa020ec477f25aaTest

3

MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation

المؤلفون: Gertrud Wiedemann, Ulrike Bacher, Katja Seipel, Thomas Pabst, Christian Messerli

المصدر: Leukemia research. 89

مصطلحات موضوعية: Adult, Male, Cancer Research, Myeloid, CD34, Peripheral blood mononuclear cell, Models, Biological, Transplantation, Autologous, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Autologous stem-cell transplantation, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Medicine, Humans, 610 Medicine & health, Aged, Retrospective Studies, business.industry, Tumor Suppressor Proteins, Hematopoietic Stem Cell Transplantation, Induction chemotherapy, Myeloid leukemia, Forkhead Transcription Factors, Hematology, Induction Chemotherapy, Middle Aged, Prognosis, Gene Expression Regulation, Neoplastic, Repressor Proteins, Haematopoiesis, Leukemia, Myeloid, Acute, MicroRNAs, medicine.anatomical_structure, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Mutation, Cancer research, Trans-Activators, Female, Stem cell, business, Nucleophosmin, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3df4593d94f150a7e9189cf98b99f336Test
https://pubmed.ncbi.nlm.nih.gov/31927137Test

4

NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma

المؤلفون: S Farese, Urban Novak, J-M Luethi, Gabriela M. Baerlocher, Thomas Pabst, Martin Bigler, Beatrice U. Mueller, B Mansouri Taleghani, Katja Seipel, Axel Ruefer, Barbara Jeker, Daniel Betticher

المصدر: Bone Marrow Transplantation. 53:175-179

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43d39d870a9a5dfeef02ee51221e0967Test
https://doi.org/10.1038/bmt.2017.234Test

5

Autologous stem cell transplantation in elderly patients with multiple myeloma: evaluation of its safety and efficacy

المؤلفون: Gabriela M. Baerlocher, Jasmin Stettler, Thomas Pabst, Katja Seipel, Urban Novak, Behrouz Mansouri Taleghani

المصدر: Stettler, Jasmin; Novak, Urban; Baerlocher, Gabriela M.; Seipel, Katja; Mansouri Taleghani, Behrouz; Pabst, Thomas (2017). Autologous stem cell transplantation in elderly patients with multiple myeloma: evaluation of its safety and efficacy. Leukemia & lymphoma, 58(5), pp. 1076-1083. Informa Healthcare 10.1080/10428194.2016.1233542 <http://dx.doi.org/10.1080/10428194.2016.1233542Test>

مصطلحات موضوعية: Adult, Male, Oncology, Melphalan, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, 610 Medicine & health, Kaplan-Meier Estimate, Transplantation, Autologous, 03 medical and health sciences, 0302 clinical medicine, Autologous stem-cell transplantation, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Multiple myeloma, Aged, Neoplasm Staging, Aged, 80 and over, Chemotherapy, business.industry, Platelet recovery, Age Factors, Hematopoietic Stem Cell Transplantation, Hematology, Middle Aged, medicine.disease, Treatment related mortality, Surgery, Immunoglobulin Isotypes, Treatment Outcome, 030220 oncology & carcinogenesis, Toxicity, Female, Stem cell, Multiple Myeloma, business, Biomarkers, 030215 immunology, medicine.drug